Brain atrophy in relapsing-remitting multiple sclerosis: Relationship with 'black holes', disease duration and clinical disability

Journal of the Neurological Sciences

Volumn 174, Issue 2, 2000, Pages 85-91

  Paolillo, Andrea ^a   Pozzilli, Carlo ^a   Gasperini, Claudio ^b   Giugni, Elisabetta ^a   Mainero, Caterina ^a   Giuliani, Saverio ^a   Tomassini, Valentina ^a   Millefiorini, Enrico ^a   Bastianello, Stefane ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Brain atrophy; EDSS; Magnetic resonance; Multiple sclerosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL FEATURE; CONTROLLED STUDY; CORPUS CALLOSUM; DISABILITY; DISEASE DURATION; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ATROPHY; BRAIN; CONTRAST MEDIA; CORPUS CALLOSUM; DISEASE PROGRESSION; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0034653442     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(00)00259-8     Document Type: Article

References (47)

1. Miller DH, Grossmann RI, Reingold SC, Me Farland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
2. Harris JO, Frank JA, Patrons N, McFarlin DE, McFarland HF. Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol 1991;29:548-55.
3. Miller DH, Albert PS, Barkhof F, Francis G, Frank JA, Hodgkinson S. Guidelines for the use of magnetic resonance technique in monitoring the treatment of multiple sclerosis. Ann Neurol 1996;39:6-16.
4. Gass A, Barker GJ, Kidd D, Thorpe JW, MacManus D, Brennan A, Tofts PS, Thompson AJ, McDonald WI, Miller DH. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62-7.
5. Filippi M, Paty DW, Kappos L, Barkhof F, Compston DA, Thompson AJ, Zhao GJ, Wiles CM, McDonald WI, Miller DH. Correlation between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up study. Neurology 1995;45:255-60.
6. Gasperini C, Horsfield M, Thorpe JW, Kidd D, Barker GJ, Tofts PS, MacManus DO, Thompson AJ, Miller DH, McDonald WI. Macroscopic and microscopic assessments of disease burden by MRI in multiple sclerosis: relationship to clinical parameters. J Magn Reson Imag 1996;6:580-4.
7. Lycklama a Nijeholt GJ, van Walderveen MAA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-97.
8. van Walderveen MAA, Barkhof F, Hommes OR, Polman CH, Tobi H, Frequin ST, Valk J. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/ short-TE (T1-weighted spin-echo images). Neurology 1995;45:1684-90.
9. Truyen L, van Waesberghe JH, van Walderveen MAA, van Oosten BW, Polman CH, Hommes OR, Ader HJ, Barkhof F. Accumulation of hypointense lesions ('black holes') on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996;47:1469-76.
10. Kidd D, Thorpe JW, Thompson AJ, Kendall BE, Moseley IF, MacManus DG, McDonald WI, Miller DH. Spinal cord MRI using multi-array coils and fast spin-echo. Neurology 1993;43:2632-7.
11. Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, Miller DH, Thompson AJ. Progressive cerebral atrophy in multiple sclerosis. A serial MRI study. Brain 1996;19:2009-19.
12. Lycklama a Nijeholt GJ, Barkhof F, Scheltens P, Castelijns JA, Ader H, van Waesberghe JH, Polman C, Jongen SJ, Valk J. MRI of the spinal cord in multiple sclerosis. A serial MRI study. Am J Neuroradiol 1997;18:1041-8.
13. Filippi M, Campi A, Colombo B, Pereira C, Martinelli V, Baratti C, Comi G. A spinal cord MRI study of benign and secondary progressive multiple sclerosis. J Neurol 1996;243:502-5.
14. Grossman RI, McGowan JC. Perspectives on multiple sclerosis. Am J Neuroradiol 1998;19:1251-65, Review.
15. van Waesberghe JH, van Walderveen MA, Castelijns JA, Scheltens P, Lycklama A Nijeholt GJ, Polman CH, Barkhof F. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. Am J Neuroradiol 1998;19(4):675-83.
16. Arnold DL, Wolinsky JS, Matthews PM, Falini A. The use of magnetic resonance spectroscopy in the evaluation of the natural history of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;1(Suppl 1):94-101.
17. McDonald WI, Miller DHM, Barnes D. The pathological evolution of multiple sclerosis. Neuropathol Appl Neurobiol 1992;18:319-34, Review.
18. Mews I, Bergmann M, Bunkoski S, Gullotta F, Brack W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Multiple Sclerosis 1998;4:55-62.
19. Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, Parker N, Kurth S, Horn SD. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. Am J Neuroradiol 1995;16:241-51.
20. Rao SM, Bernardin L, Leo GJ, Ellington L, Ryan SB, Burg LS. Cerebral disconnection in multiple sclerosis: relationship to atrophy of the corpus callosum. Arch Neurol 1989;46:918-20.
21. Pozzilli C, Bastianello S, Padovani A, Passafiume D, Millefiorini E, Bozzao L, Fieschi C. Anterior corpus callosum atrophy and verbal fluency in multiple sclerosis. Cortex 1991;27:441-5.
22. Swirsky-Sacchetti T, Mitchell DR, Seward J, Gonzales C, Lublin F, Knobler R, Field HL. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 1992;42:1291-5.
23. Poser CM, Paty DW, Scheimberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-31.
24. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-52.
25. Davie CA, Barker GJ, Webb S, Tofts PS, Thompson AJ, Harding AE, McDonald WI, Miller DH. Persistent deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;118:1583-92.
26. Grimaud J, Lai M, Thorpe J, Adeleine P, Wang L, Barker GJ, Plummer DL, Tofts PS, McDonald WI, Miller DH. Quantification of MRI lesion load in multiple sclerosis: a comparison of three computed-assisted techniques. Magn Reson Imaging 1996; 14:495-505.
27. Bland JM, Altman DG. Statistical methods of assessing agreement between two methods of clinical measurements. Lancet 1986;1:307-10.
28. Paolillo A, Coles AJ, Molineux PD, GawneCain M, MacManus D, Barker GJ, Compston DAS, Miller DH. Quantitative MRI in patients with secondary progressive MRI treated with monoclonal antibody Campath 1H. Neurology 1999;53:751-7.
29. Coles AJ, Wing MG, Molyneux PD, Paolillo A, Davie CM, Geoff H, Miller D, Waldmann H, Compston A. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis. Ann Neurol 1999;46:296-304.
30. Loizou LA, Rolfe EB, Hewazy H. Cranial computed tomography in the diagnosis of multiple sclerosis. J Neurol Neurosurg Psychiatry 1982;45:905-12.
31. Noseworthy JH, Paty DW, Ebers GC. Neuroimaging in multiple sclerosis. Neurol Clin 1984;2:759-77.
32. Rao SM, Glatt S, Hammeke TA, McQuillen MP, Khatri BO, Rhodes AM, Pollard S. Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and neuropsychological impairment. Arch Neurol 1985;42:678-82.
33. Huber SJ, Paulson GW, Shuttleworth EC, Chakeres D, Clapp LE, Pakalnis A, Weiss K, Rammohan K. Magnetic resonance imaging correlates of dementia in multiple sclerosis. Arch Neurol 1987;44(7):732-6.
34. Filippi M, Mastronardo G, Rocca MA, Pereira C, Comi G. Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 1998;158:148-53.
35. Liu C, Edwards SGM, Gong Q, Roberts N, Blumhardt LD. Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1999;66:323-30.
36. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85.
37. Kertesz A, Polk M, Howell J, Black SE. Cerebral dominance, sex and callosal size in MRI. Neurology 1987;37:1385-8.
38. Witelson SF. Hand and sex differences in the isthmus and genu of the human corpus callosum; a postmortem morphological study. Brain 1989;112:799-835.
39. Pelletrier J, Habib M, Lyon-Caen O, Salamon G, Poncet M, Khalil R. Functional and magnetic resonance imaging correlates of callosal involvement in multiple sclerosis. Arch Neurol 1993;50:1077-82.
40. Barkhof F, Elton M, Lindeboom J, Tas MW, Schmidt WF, Hommes OR, Polman CH, Kok A, Valk J. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study. J Neurol 1998;245:153-8.
41. The Multiple Sclerosis Collaborative Research Group, Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fisher JS, Goodkin DE, Simonian N, Lajaunie M, Miller DE, Wende K, Martens-Davidson A, Kinkel RP, Munschauer FE, Brownscheidle CM. A longitudinal study of brain atrophy in relapsing multiple sclerosis. Neurology 1999;53:139-48.
42. van Walderveen MA, Kamphorst W, Scheltens P, van Waesberghe JH, Ravid R, Valk J, Polman CH, Barkhof F. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998;50(5):1282-8.
43. Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 1994;51:874-87.
44. Blatter DD, Bigler ED, Gur RC, Johnson SC, Anderson CV, Burnett BM, Parker N, Kurth S, Horn SD. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. Am J Neuroradiol 1995;16:241-51.
45. Giugni E, Pozzilli C, Bastianello S, Gasperini C, Paolillo A, Koudriavtseva T, Frontoni M, Farina D, Bozzao L. MRI measures and their relations with clinical disability in relapsing-remitting and secondary progressive multiple sclerosis. Multiple Sclerosis 1997;3:221-5.
46. Edwards SGM, Gong QY, Liu C, Zvartau ME, Jaspan T, Roberts N, Blumhardt LD. Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 1999;122:291-301.
47. Willoughby EW, Paty DW. Scales for rating impairment in multiple sclerosis: a critique. Neurology 1988;38:1793-8.